Skip to content

Assessment of efficacy of antenatal betamethasone on neonatal respiratory outcome of late preterm delivery (34-37 weeks)

Assessment of efficacy of antenatal betamethasone on neonatal respiratory outcome of late preterm delivery (34-37 weeks) in singleton pregnancies

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120918010876N3
Enrollment
200
Registered
2017-12-16
Start date
2017-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory distress syndrome of newborn. Respiratory distress syndrome of newborn

Interventions

Intervention 1: Treatment group: intramuscular injection of 12 mg betamethasone in two doses between 24 hours. Intervention 2: Control group: No Treatment.
Treatment - Drugs
Treatment group: intramuscular injection of 12 mg betamethasone in two doses between 24 hours

Sponsors

Shahid Beheshti University of Medical Sciences- Mahdieh Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Singleton pregnancy Gestational age from 34 weeks and 0 days to 36 weeks and 6 days High probability of preterm labor (in weeks 37-34) due to premature rupture of membranes Preterm labor with intact membranes preterm labor with any indication (including previous cesarean section, intrauterine growth retardation (IUGR), Oligohydramnios, pre-eclampsia, etc.)

Exclusion criteria

Exclusion criteria: No exact gestational age (unknown firt day of last menstrual period (LMP) or no ultrasound dating) Cervix dilatation of 4 cm or more Planned delivery after 36 weeks and 6 days Known congenital malformations Received corticosteroids before week 34 or for other indications Fetal death Major fetal anomaly Non-viable fetus Gestational diabetes Diabetes before pregnancy Maternal contraindications for betamethasone Chorioamnionitis

Design outcomes

Primary

MeasureTime frame
Neonatal respiratory outcomes. Timepoint: After delivery until patient discharge. Method of measurement: Clinical symptoms & signs.;NICU admission. Timepoint: After delivery until patient discharge. Method of measurement: Clinical symptoms & signs.;Hospitalization duration. Timepoint: Patient discharge time. Method of measurement: Hospitalization duration in day and hour.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Masoome Mirzamoradi

Shahid Beheshti University of Medical Sciences- Mahdieh Hospital

drmoradi000@yahoo.com+98 21 5506 6263

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026